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Background: Neoadjuvant chemoradiation therapy followed by curative surgery has gained acceptance as the
therapy of choice in locally advanced rectal cancer. However, deterioration of anorectal function after long-course
neoadjuvant chemoradiation therapy combined with surgery for rectal cancer is poorly defined. The aim of this
study was to evaluate the physiological and clinical change of anorectal function after neoadjuvant chemoradiation
therapy for rectal cancer.
Methods: We analyzed 30 patients on whom preoperative anorectal manometry data were available both before
and after chemoradiation from October 2010 to September 2011. All patients underwent long-course neoadjuvant
chemoradiation therapy. We compared manometric parameters between before and after neoadjuvant
chemoradiation therapy.
Results: Of 30 patients, 20 were males and 10 females. The mean age was 64.9 ± 9.9 years (range, 48-82). Before
nCRT, the rectal compliance was higher in patients with ulceroinfiltrative type (P = 0.035) and greater involvement
of luminal circumference (P = 0.017). However, there was the tendency of increased rectal sensory threshold for
desire to defecate when the patient had decreased circumferential ratio of the tumor (P = 0.099), down-graded
T stage (P = 0.016), or reduced tumor volume (P = 0.063) after neoadjuvant chemoradiation.
Conclusions: Neoadjuvant chemoradiation therapy did not significantly impair overall sphincter function before
radical operation. The relationship between tumor response of chemoradiation and sensory threshold for desire to
defecate may suggest that neoadjuvant chemoradiation may be helpful for defecatory function as well as local
disease control, at least in the short-term period after the radiation in locally advanced rectal cancer patients.
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Neoadjuvant chemoradiation therapy (nCRT) followed
by curative surgery has become the therapy of choice in
locally advanced rectal cancer. The nCRT was intro-
duced to improve local control and some studies have
demonstrated a significant benefit from this treatment
with reduced local recurrence rates [1]. Low anterior
resection (LAR) with total mesorectal excision (TME) is
the standard surgical procedure in sphincter-preserving* Correspondence: hmcho@catholic.ac.kr
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reproduction in any medium, provided the orsurgery for rectal cancer [2]. Currently, a combined-
modality therapy including surgery, radiotherapy, and
chemotherapy is recommended for the majority of patients
with stage II or III rectal cancer.
However, deterioration of anorectal function after nCRT
combined with sphincter-preserving surgery (SPS) for
rectal cancer may happen. Although factors that may
affect on postoperative bowel function are not predictable
and not well understood, nCRT and LAR with TME can be
important ones that may influence anorectal function [3-5].
Many investigators have reported defecatory dysfunction
such as frequent defecation, urgency, and incontinence
after sphincter-saving procedure, especially with low. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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anorectal function after nCRT for locally advanced rec-
tal cancer is often referred as radiation damage of the
anorectum and pelvic floor [8,9].
Until recently, most of the studies about the effects of
nCRT on anorectal function have assessed pre-nCRT
and long-term postoperative results [3-6,8]. However,
SPS alone could also adversely affect the outcome of
anorectal function and it could introduce a significant
bias in the assessment of the impact of nCRT. There are
a few studies that reported short-term effect of nCRT on
anorectal function [10,11]. In that studies, the authors
found no significant changes of manometric data after
nCRT and concluded that fecal incontinence after SPS
should not be the result of radiotherapy. However, they did
not evaluate the relationship between the tumor response
and the change of anorectal function.
In this study, we aimed to evaluate the preoperative
short-term effects of nCRT on anorectal function and
the relationship between the tumor response for nCRT
and the change of anorectal function.
Methods
We prospectively collected manometric data before and
after nCRT in patients who were diagnosed with adeno-
carcinoma of rectum below 12 cm from the anal verge
by rigid proctosigmoidoscopy before nCRT from October
2010. Among these patients, 30 patients whose preopera-
tive manomertic data were available at both before and
after nCRT from October 2010 to September 2011 were
enrolled in this study. After obtaining review board ap-
proval from our institute (VC12RISI0016), we analyzed
manometric data and clinical information of these 30
patients retrospectively.
Clinical stage was determined according to the American
Joint Committee on Cancer Six Staging System. All 30 pa-
tients had clinical T3 to T4 or N positive tumors. All of the
analyzed patients received neoadjuvant radiotherapy with
conventional fractionation as follows: 1.8 Gy per day; five
fractions per week; and total dose, 50.4 Gy/28 fractions
(45 Gy/25 fractions initially to the whole pelvis, followed by
5.4 Gy/3 fractions as a boost to the gross tumor). All of the
patients received two cycles of concurrent chemotherapy
with radiotherapy (5-fluorouracil [5-FU], 400 mg/m2
[IV] 1 h before radiotherapy and leucovorin, 20 mg/m2
[IV] immediately before each dose of 5-FU on days 1–5
and days 29–33).
Anorectal manometry was performed before nCRT
and three to four weeks after the end of nCRT with the
water-perfusion technique using an 8-channel Micro Tip
catheter connected to a perfusion pump (POLYGRAF ID;
Alpine Biomed, Denmark). Manometric data including
mean resting pressure (MRP), maximum squeezing
pressure (MSP), the percentages of asymmetry of resting(R asymmetry) and squeezing (S asymmetry) sphincter,
the length of high-pressure zone (HPZ) at resting and
squeezing, recto-anal inhibitory reflex (RAIR), rectal
sensory threshold (RST), and rectal compliance. RST
was measured via determination of threshold volume
of the first minimal sensation, desire to defecate, and
maximal tolerance. All manometry procedures were
performed by a single practitioner who has performed
anal physiologic test over 5 years.
We compared manometric data before nCRT according
to tumor location from the anal verge, tumor gross morph-
ology, tumor circumferential ratio (CIR) and T stage. Also,
we evaluated tumor response after nCRT with above factors
adding tumor volume. We divided our patients into two
groups according to tumor location from the anal verge
whether the lower margin of tumor was >5 cm or ≤ 5 cm
from anal verge by rigid proctosigmoidoscopy. For patients
with tumor below 5 cm from the anal verge, the field of
additional booster on peritumoral region included the anal
canal. However, in tumor above 5 cm from the anal verge,
the anal canal and perineum were excluded from the field
of additional booster. This was the reason that we divided
out patients with 5 cm criteria. Tumor gross morphology
on flexible colonofiberscopy was classified to three cat-
egories; fungating, ulcerofungating, and ulceroinfiltrative.
Tumor CIR was defined as a ratio of the circumference of
infiltrative component of tumor to luminal circumference.
We used trans-rectal ultrasound to measure tumor CIR.
CIR was classified into four categories; CIR ≤ 1/4, CIR ≤ 1/2,
CIR ≤ 3/4, and CIR >3/4. T stage was also measured by
trans-rectal ultrasound. We defined reduction of tumor
volume as more than 70% of decreased tumor volume
after nCRT by CT volumetry. Rigid proctosigmoidoscopy,
flexible colonofiberscopy, and trans-rectal ultrasound were
performed by the colorectal surgeons whose sub-specialty is
colorectal disease in Korea and are co-authors in this study.
The difference of manometric data between before and
after nCRT was measured by subtraction from manometric
data before nCRT to that after nCRT. The negative value
means that value of manometric data after nCRT was
increased comparing to that before nCRT.
Continuous variables between two groups were compared
using the Student’s t-test and expressed as mean ± SD.
Categorical variables were analyzed with χ2 test. Although
significance was defined as P ≤ 0.05, P ≤ 0.1 was regarded
as marginal significance. All statistical analyses were
performed using the Statistical Package of the Social
Sciences (SPSS) version 15.0 for Windows (SPSS, Inc,
Chicago, IL).
Results
Of 30 patients, there were 20 males and 10 females.
The mean age was 64.9 ± 9.9 years (range, 48–82). All
patients did not experience any radiation-related or
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grade 3 reaction according to the Common Toxicity
Criteria. There was a marginal difference in the max-
imal rectal sensory threshold between before and after
nCRT (179.3 ± 63.7 ml vs 151.7 ± 53.4 ml, P = 0.073)
without a difference in rectal compliance (P = 0.638)
(Table 1). There were four patients whose RAIR were
absent before CRT. However, this reflex was recovered
after nCRT in these four patients.
In manometry performed before nCRT, the maximal RST
was marginally higher in patients with ulceroinfiltrative
type than ulcerofungating type (212.5±80.3 ml vs
167.2±53.7ml, P = 0.086) and the rectal compliance was
significantly higher in patients with ulceroinfiltrative
type than ulcerofungating type (1.9 ± 1.1 ml/mmHg vs
1.2 ± 0.6 ml/mmHg, P = 0.035). Also, as smaller involve-
ment of luminal circumference, the maximal RST was
higher marginally (P = 0.083) and the rectal compliance
was significantly higher (P = 0.017) (Table 2).
When we considered the effect of nCRT on tumor,
there were twenty two patients who underwent the change
of tumor gross morphology after nCRT, ten patients with
reduced CIR after nCRT, eight patients with down-staging
in T-stage, and four patients with more than 70% of volume
reduction of tumor after nCRT. When we considered the
effect of nCRT on anorectal function, there were no signifi-
cant differences on the changes of manometric data be-
tween before and after nCRT according to the tumor
location from the anal verge and the change of tumor gross
morphology. Patients who had tumor with reduced CIR
after nCRT had the tendency of improved RST for ‘desireTable 1 Comparison of manometric data between before






MRP (mmHg) 93.5 ± 44.7 80.3 ± 32.4 0.195
R asymmetry (%) 22.3 ± 12.9 23.9 ± 9.7 0.572
MSP (mmHg) 348.8 ± 177.2 285.2 ± 111.7 0.102
S asymmetry (%) 17.2 ± 11.6 16.3 ± 4.8 0.667
HPZ length at rest (cm) 1.8 ± 0.6 1.8 ± 0.8 0.789
HPZ length at squeezing (cm) 2.2 ± 0.5 2.3 ± 0.8 0.634
RAIR (ml) 37.3 ± 13.6 40.7 ± 9.8 0.281
Rectal sensory threshold (ml)
First 63.0 ± 32.1 57.3 ± 18.9 0.408
Desire to defecate 117.3 ± 46.5 108.7 ± 42.3 0.453
Maximal 179.3 ± 63.7 151.7 ± 53.4 0.073
Rectal compliance (ml/mmHg) 1.4 ± 0.8 1.3 ± 0.7 0.638
MRP Mean Resting Pressure, R asymmetry asymmetry of the resting sphincter,
MSP Maximal Squeezing Pressure, S asymmetry asymmetry of the squeezing
sphincter, HPZ High Pressure Zone, RAIR Recto-Anal Inhibitory Reflex, nCRT
neoadjuvant chemoradiation therapy.to defecate’ (P = 0.099). Those patients with down-staging
in T stage showed elongated HPZ length (P = 0.030),
decreased volume for RAIR (P = 0.029), and improved
RST for ‘desire to defecate’ (P = 0.016). Although there was
no significance, patients with tumor volume reduction after
nCRT showed the tendency of increased RST for ‘desire to
defecate’ (P = 0.063) (Table 3).
Discussion
The majority of patients with rectal cancer have received
external pelvic radiation therapy for local control of tu-
mors. The nCRT has been preferred due to lower 5-year
locoregional recurrence and better sphincter preservation
[1]. Anorectal function may deteriorate after SPS with
TME. Some studies have described the “anterior resection
syndrome” as an increased number of daily bowel move-
ments, clustering, anal incontinence, and soiling after SPS
[12]. An increase in number of stools, frequent use of
pads, urgency of defecation, impaired sensory perception,
and fecal incontinence may occur after pelvic radiation
[9,13-15]. Hence, it is well conceivable that nCRT may
cause additional damage to sphincter function after SPS
with TME. However, the data about short-term preopera-
tive change of anorectal function based on manometric
data after nCRT were limitd [10,11]. Especially, the report
for the change of manometric data regarding to tumor
response after nCRT has not been published.
In this study, we examined the effect of nCRT on
anorectal function in three aspects; the change of ano-
rectal function by rectal irradiation, that according to
whether anal sphincter was irradiated or not by additional
booster on peritumoral region, and that according to the
tumor response.
Firstly, we investigated the change of anorectal function
by rectal irradiation. Some studies about postoperative
change of anorectal function demonstrated that the RAIR
is stimulated by intramural nervous pathways. These ner-
vous pathways might be injured during the dissection of
the rectum, then the RAIR will be absent postoperatively
[16,17]. However, two studies about the short-term pre-
operative change of anorectal function after nCRT demon-
strated that the RAIR is present in all patients both before
and after nCRT and there is no change in RAIR between
them [10,11]. In our study, the RAIR was not changed after
nCRT (37.3 ± 13.6 mL vs 40.7 ± 9.8 mL, P = 0.281). There
were four patients who were absent of the RAIR before
nCRT, however, the RAIR was present after nCRT in
these four patients. This finding may imply that the reflex
mechanism was not damaged by nCRT in short-term
period after nCRT. When we analyzed the data from all
30 patients, the maximal RST was decreased after nCRT
(179.3 ± 63.7 mL vs 151.7 ± 53.4 mL, P = 0.073). However,
rectal compliance was not changed much after nCRT
(1.4 ± 0.8 mL/mmHg vs 1.3 ± 0.7 mL/mmHg, P = 0.638).
Table 2 Comparison of manometric data before nCRT according to each tumor characteristics





P-value UF (n = 22) UI (n = 8) P-value R1 (n = 15) R2 (n = 10) R3 (n = 5) P-value T3 (n = 27) T4 (n = 3) P-value
MRP (mmHg) 89.4 ± 41.7 99.6 ± 50.1 0.550 97.8 ± 46.4 81.7 ± 39.9 0.393 79.6 ± 38.7 99.3 ± 38.4 123.5 ± 62.9 0.144 88.4 ± 43.6 138.8 ± 26.6 0.063
R asymmetry (%) 20.7 ± 5.8 24.6 ± 19.5 0.427 22.8 ± 14.5 20.8 ± 7.5 0.725 21.4 ± 6.8 17.6 ± 5.8 34.1 ± 27.3 0.059 23.1 ± 13.3 14.9 ± 3.9 0.310
MSP (mmHg) 313.7 ± 116.5 401.3 ± 238.2 0.189 345.9 ± 200.8 356.5 ± 94.4 0.888 319.7 ± 91.5 353.6 ± 121.6 425.9 ± 392.7 0.523 351.1 ± 183.7 328.5 ± 124.5 0.839
S asymmetry (%) 15.9 ± 4.1 19.2 ± 17.9 0.470 18.2 ± 13.3 14.7 ± 3.2 0.485 15.3 ± 4.2 13.9 ± 3.3 29.4 ± 25.6 0.029 17.8 ± 12.1 12.1 ± 2.2 0.424
HPZ length at rest (cm) 1.7 ± 0.6 1.9 ± 0.5 0.512 1.8 ± 0.6 1.6 ± 0.4 0.438 1.6 ± 0.5 1.7 ± 0.6 2.1 ± 0.7 0.416 1.7 ± 0.6 1.8 ± 0.7 0.829
HPZ length at squeezing (cm) 2.3 ± 0.5 2.1 ± 0.3 0.147 2.2 ± 0.5 2.1 ± 0.3 0.251 2.0 ± 0.3 2.3 ± 0.6 2.6 ± 0.4 0.059 2.1 ± 0.4 2.8 ± 0.7 0.017
RAIR (ml) 36.7 ± 14.1 38.3 ± 13.4 0.749 38.2 ± 8.5 35.0 ± 23.3 0.581 40.0 ± 13.1 36.0 ± 12.6 32 ± 17.8 0.504 37.1 ± 14.3 40.0 ± 0.1 0.728
Rectal sensory threshold (ml)
First 65.6 ± 37.9 59.2 ± 21.5 0.602 63.2 ± 35.1 62.5 ± 23.7 0.960 71.3 ± 41.5 59.0 ± 17.9 46.0 ± 0.5 0.258 62.9 ± 32.6 63.3 ± 32.1 0.985
Desire to defecate 116.1 ± 45.8 119.2 ± 49.4 0.863 116.8 ± 43.4 118.7 ± 57.4 0.922 204.0 ± 66.2 162.0 ± 57.3 179.3 ± 63.7 0.297 117.1 ± 45.1 120.0 ± 69.2 0.919
Maximal 174.4 ± 57.2 186.7 ± 74.5 0.615 167.2 ± 53.7 212.5 ± 80.3 0.086 204.0 ± 66.2 162.0 ± 57.3 140.0 ± 41.8 0.083 177.1 ± 65.4 200.0 ± 50.0 0.563
Rectal compliance (ml/mmHg) 1.4 ± 0.8 1.3 ± 0.7 0.852 1.2 ± 0.6 1.9 ± 1.1 0.035 1.8 ± 0.9 1.1 ± 0.5 0.8 ± 0.5 0.017 1.4 ± 0.8 1.0 ± 0.2 0.346
MRP Mean Resting Pressure, R asymmetry asymmetry of the resting sphincter, MSP Maximal Squeezing Pressure, S asymmetry asymmetry of the squeezing sphincter, HPZ High Pressure Zone, RAIR Recto-Anal Inhibitory
















Table 3 Comparison of the difference of manometric data between before and after nCRT according to each tumor characteristics






















MRP (mmHg) 8.2 ± 26.9 20.7 ± 39.2 0.304 12.1 ± 24.5 13.6 ± 35.3 0.914 9.1 ± 25.4 21.5 ± 43.6 0.331 16.2 ± 32.6 4.9 ± 32.3 0.404 12.4 ± 33.8 18.6 ± 23.5 0.726
R asymmetry (%) −3.8 ± 5.9 1.5 ± 23.7 0.371 −3.5 ± 5.0 −1.1 ± 17.9 0.700 −3.7 ± 5.7 2.5 ± 26.0 0.311 −10.1 ± 15.9 −3.4 ± 15.5 0.731 −2.2 ± 16.6 1.5 ± 3.1 0.670
MSP (mmHg) 39.5 ± 73.4 99.6 ± 261.9 0.362 21.9 ± 73.4 78.6 ± 197.1 0.438 35.2 ± 71.8 120.1 ± 284.1 0.212 74.6 ± 196.5 33.1 ±85.8 0.571 63.2 ± 184.2 65.5 ± 89.9 0.981
S asymmetry (%) −0.7 ± 4.3 3.6 ±18.5 0.348 0.3 ± 3.8 1.3 ± 13.9 0.843 −1.2 ± 4.5 5.4 ± 19.8 0.162 1.2 ± 13.9 0.4 ±3.6 0.869 0.8 ± 12.9 2.0 ±1.2 0.860
HPZ length at
rest (cm)
−0.1 ± 0.6 0.08 ±0.7 0.345 0.2 ± 0.6 −0.1 ± 0.6 0.140 −0.08 ± 0.6 0.02 ± 0.7 0.677 0.1 ± 0.5 −0.4 ±0.6 0.030 0.008 ±0.5 −0.4 ±0.8 0.215
HPZ length at
squeezing (cm)
−0.02 ± 0.8 −0.2 ± 0.8 0.612 0.01 ± 1.0 −0.1 ± 0.7 0.696 −0.1 ± 0.9 −0.02 ± 0.4 0.762 −0.1 ± 0.8 0.06 ± 0.7 0.551 −0.06 ± 0.6 −0.3 ±0.3 0.658
RAIR (ml) −2.2 ± 18.1 −5.0 ± 15.1 0.663 −7.5 ± 18.3 −1.8 ± 16.2 0.419 −4.0 ± 17.9 −2.0 ± 14.7 0.763 −7.3 ± 15.8 7.5 ± 14.8 0.029 −4.6 ± 17.3 5.0 ±10.0 0.291
Rectal sensory
threshold (ml)
First 8.3 ± 38.8 1.7 ±21.2 0.593 16.25 ± 56.6 1.8 ± 18.7 0.292 4.0 ± 10.5 9.0 ± 56.5 0.700 10.0 ± 32.9 −6.2 ± 30.7 0.235 7.3 ±31.3 −5.0 ±44.3 0.493
Desire to defecate 9.4 ± 51.5 7.5 ± 51.9 0.920 31.3 ± 64.2 0.5 ± 43.8 0.145 19.5 ± 32.4 −13.0 ± 72.9 0.099 21.8 ± 41.7 −27.5 ± 58.5 0.016 15.4 ±45.3 −35.0 ± 70.0 0.063
Maximal 28.9 ± 55.2 25.8 ±49.4 0.878 41.3 ± 57.2 22.7 ± 50.6 0.399 36.5 ± 50.1 10.0 ± 54.2 0.194 30.9 ±58.1 18.8 ± 31.8 0.581 29.6 ± 54.9 15.0 ±30.0 0.610
Rectal compliance
(ml/mmHg)
0.2 ± 0.7 −0.07 ± 0.5 0.283 0.1 ± 0.7 0.07 ± 0.7 0.794 0.2 ± 0.7 −0.1 ± 0.5 0.206 0.1 ±0.7 0.006 ± 0.5 0.675 0.1 ± 0.7 −0.3 ± 0.5 0.223
MRP Mean Resting Pressure, R asymmetry asymmetry of the resting sphincter, MSP Maximal Squeezing Pressure, S asymmetry asymmetry of the squeezing sphincter, HPZ High Pressure Zone, RAIR Recto-Anal Inhibitory
Reflex, CIR Circumferential ratio.
† For patients with tumor below 5 cm from the anal verge, the field of additional booster on peritumoral region included the anal canal. However, in tumor above 5 cm from the anal verge, the anal canal and
perineum were excluded from the field of additional booster.
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apy, demonstrated that acute changes of the rectum in-
cluded mucosal edema and patchy fibroblastic proliferation
in the lamina propria. They found that cellular epithelial
damage appeared early after radiotherapy whereas architec-
tural epithelial damage appeared late after radiotherapy.
This may explain the unchanged rectal compliance in early
period after nCRT. The decrease of maximal RST and the
maintenance of rectal compliance may imply that rectal
hypersensitivity without the change of rectal elasticity was
induced by nCRT in early period after nCRT.
Secondly, we intended to investigate the change of anal
sphincter function after nCRT by comparing two groups
divided by whether anal sphincter was irradiated or not by
additional booster on peritumoral region. In this study, we
compared changes of manometric data between before and
after nCRT according to tumor location with 5 cm criteria.
For patients with tumor below 5 cm from the anal verge,
the field of additional booster on peritumoral region in-
cluded the anal canal. However, in tumor above 5 cm from
the anal verge, the anal canal and perineum were excluded
from the field of additional booster. As shown in Table 3,
MRP, MSP, sphincter asymmetry, and HPZ length, which
reflect sphincter function, were not significantly different
between these two groups. This means that irradiation
on sphincter complex did not affect sphincter function
in short-term period after nCRT. This is similar to other
studies that compared changes of manometric data be-
tween mid and low rectal cancer after nCRT [11,19].
Finally, we investigated the change of anorectal function
according to tumor response. For this, we had observed the
changes of manometric data according to the tumor re-
sponse for nCRT, classifying four factors; change of tumor
gross morphology, CIR, T stage, and tumor volume. In this
study, rectal compliance (P = 0.035) and the maximal RST
(P = 0.086) were lower in patients who had ulcerofungating
type than in ulceroinfiltrative type before nCRT.
This outcome can be interpreted as the fungating
component of tumor might affect anorectal function
negatively, which led to bad influence on defecation
symptom of those patients before nCRT. However, we
observed that most patients (22/30, 73.3%) showed changes
of tumor gross morphology from ulcerofungating type to
ulceroinfiltrative type after nCRT. As shown in Table 3, the
change of tumor gross morphology between before and
after nCRT did not affect to the change of anorectal func-
tion. This finding shows that the response of fungating
component of tumor to nCRT doesn’t significantly relate to
the change of anorectal function. Lee et al. [20] demon-
strated that preoperative rectal reservoir function is altered
by the existence of a tumor and tumor infiltration may alter
the anorectal function because the ulceroinfiltrative type
was correlated with intramural distal spread. Thus, it can
be said that we should focus on infiltrating componentsrather than fungating components when we evaluate rec-
tal reservoir and anorectal function. In this study, tumor
volume, CIR, and T stage were examined to evaluate the
response of infiltrating component to nCRT. Though the
fungating components take a significant sum in tumor
volume, we assumed that infiltrating components should
be reduced in some degrees if there was a volume reduction
at all. Considering the volume reduction after nCRT, we
could observe that the RST for desire to defecate was im-
proved in the patients who had tumor which was decreased
more than 70% of its volume. From these findings, we
thought that marked volume reduction including infiltrative
component of tumor could improve anorectal function
after nCRT. We observed that as the CIR was higher,
the maximal RST (P = 0.086) and the rectal compliance
(P = 0.017) were lower before nCRT. This may explain
that the extent of infiltrative component of tumor can
be involved in the anorectal function before nCRT.
After nCRT, although the changes of the maximal RST
and rectal compliance were not significantly different
between patients with and without reduced CIR, the
RST for desire to defecate in patients with reduced CIR
was marginally higher than that in patients without re-
duced CIR (P = 0.099). This finding may suggest that in
addition to the effect of radiation on normal tissue, the
effect of radiation on tumor can affect the rectal sensory
as well, to improve anorectal function, inversely. Although
there was no significant difference in RST according to T
stage before nCRT, the RST for desire to defecate was sig-
nificantly higher in patients with down staging after nCRT
than in patients without down staging (P = 0.016). How-
ever, these changes of manometric data resulted not from
improving the RST for desire to defecate in patients with
reduced CIR or T stage but from worsening in patients
without those. This means that good tumor response with
nCRT offset the negative effect for anorectal function,
especially sensory function, worsened by nCRT.
Jang et al. [11] demonstrated that the observed decrease
of maximal tolerance volume and rectal compliance was in
contradiction with the improvement of clinical symptoms
observed after nCRT. They explained the reason by a
positive effect on clinical impact of tumor downsizing.
Although these findings are similar to our study, our
study suggested more concrete result for the relationship
between the change of anorectal function and the tumor
response. In summary, the nCRT might affect the RST
positively when the infiltrative component of tumor had
a response with booster dose for tumor, but irradiated
rectum and sphincter complex might not be affected.
Our results give the information about short-term anorectal
function in regard to future strategies like omitting major
surgery in patients with complete response after nCRT or
applying those findings (especially in the group with tumors
located < 5 cm from anal verge) to patients with anal
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alone, although higher doses and different chemotherapy
agents are used.
This study has some limitations such as use of retro-
spective analysis, a small number of patients, and omitting
evaluation of clinical symptoms. However, there are not
any reports searching about the short-term relationship
with quantitative assessment between anorectal function
and tumor response after nCRT for rectal cancer.
Conclusions
In conclusion, the nCRT did not impair overall sphincter
function before radical operation significantly. In this
study, when tumor was shrunk or down-staged, the RST
for desire to defecate was increased. Especially, those pa-
tients who showed down-staging by transrectal ultrasonog-
raphy had significantly increased rectal sensory threshold
for desire to defecate. This finding may suggest that nCRT
may be helpful for their defecatory function in patients with
radiosensitive rectal cancer as well as local disease control,
at least in the short-term period of nCRT.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
A study conception and design: K and C. Acquisition of data: K, HJK, SHK, L,
and C. Analysis and interpretation of data: K, HJK, JGK, S, and C. Drafting of
manuscript: K, HJK, JGK, SHK, S, L, and C. Critical revision: K, HJK, and C.
Final approval: K, HJK, JGK, SHK, S, L, and C. All authors read and approved the
final manuscript.
Author details
1Department of Surgery, St. Vincent Hospital, The Catholic University of
Korea, Suwon, Korea. 2Department of Surgery, Seoul St. Mary’s Hospital, The
Catholic University of Korea, Seoul, Korea. 3Department of Radiation
Oncology, St. Vincent Hospital, The Catholic University of Korea, Suwon,
Korea. 4Department of Medical Oncology, St. Vincent Hospital, The Catholic
University of Korea, Suwon, Korea.
Received: 8 January 2013 Accepted: 16 August 2013
Published: 20 August 2013
References
1. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P,
Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab
R: German Rectal Cancer Study Group: Preoperative versus postoperative
chemoradiotherapy for rectal cancer. New Engl J Med 2004, 351:1731–1740.
2. Heald RJ, Ryall RD: Recurrence and survival after total mesorectal excision
for rectal cancer. Lancet 1986, 28:1479–1482.
3. Dahlberg M, Glimelius B, Graf W, Påhlman L: Preoperative irradiation
affects functional results after surgery for rectal cancer: results from
a randomized study. Dis Colon Rectum 1998, 41:543–551.
4. Matzel KE, Bittorf B, Günther K, Stadelmaier U, Hohenberger W: Rectal resection
with low anastomosis: functional outcome. Colorectal Dis 2003, 5:458–464.
5. Matzel KE, Stadelmaier U, Muehldorfer S, Hohenberger W: Continence after
colorectal reconstruction following resection: impact of level of
anastomosis. Int J Colorectal Dis 1997, 12:82–87.
6. Williams N, Seow-Choen F: Physiological and functional outcome
following ultra-low anterior resection with colon pouch-anal
anastomosis. Br J Surg 1998, 85:1029–1035.
7. Ammann K, Kirchmayr W, Klaus A, Muhlmann G, Kafka R, Oberwalder M,
De Viries A, Ofner D, Wueiss H: Impact of neoadjuvant chemoradiation on
anal sphincter function in patients with carcinoma of the mid rectum
and low rectum. Arch Surg 2003, 138:257–261.8. Iwamoto T, Nakahara S, Mibu R, Hotokezaka M, Nakano H, Tanaka M: Effect
of radiotherapy on anorectal function in patients with cervical cancer.
Dis Colon Rectum 1997, 40:693–697.
9. Yeoh E, Sun WM, Russo A, Ibanez L, Horowitz M: A retrospective study of
the effects of pelvic irradiation for gynecological cancer on anorectal
function. Int J Radiat Oncol Biol Phys 1996, 35:1003–1010.
10. Birnbaum EH, Dreznik Z, Myerson RJ, Lacey DL, Fry RD, Kodner IJ, Fleshman JW:
Early effect of external beam radiation therapy on the anal sphincter:
a study using anal manometry and transrectal ultrasound.
Dis Colon Rectum 1992, 35:757–761.
11. Jang NY, Han TJ, Kang SB, Kim DW, Kim IA, Kim JS: The short-term effect of
neoadjuvant chemoradiation on anorectal function in low and midrectal
cancer: analysis using preoperative manometric data. Dis Colon Rectum
2010, 53:445–449.
12. Williamson ME, Lewis WG, Holdsworth PJ, Finan PJ, Johnston D: Decrease
in the anorectal pressure gradient after low anterior resection of the
rectum. A study using continuous ambulatory manometry. Dis Colon
Rectum 1994, 37:1228–1231.
13. Putta S, Andreyev HJ: Faecal incontinence: a late side-effect of pelvic
radiotherapy. Clin Oncol 2005, 17:469–477.
14. Varma JS, Smith AN, Busuttil A: Correlation of clinical and manometric
abnormalities of rectal function following chronic radiation injury.
Br J Surg 1985, 72:875–878.
15. Vordermark D, Sailer M, Flentje M, Thiede A, Kölbl O: Curative-intent
radiation therapy in anal carcinoma: quality of life and sphincter
function. Radiother Oncol 1999, 52:239–243.
16. Efthimiadis C, Basdanis G, Zatagias A, Tzeveleki I, Kosmidis C, Karamanlis E,
Harlaftis N: Manometric and clinical evaluation of patients after low
anterior resection for rectal cancer. Tech Coloproctol 2004, 8:S205–S207.
17. Horgan AF, Molloy RG, Coulter J, Sheehan M, Kirwan WO: Nerve
regeneration across colorectal anastomoses after low anterior resection
in a canine model. Int J Colorectal Dis 1993, 8:167–169.
18. Haboubi NY, Schofield PF, Rowland PL: The light and electron microscopic
features of early and late phase radiation-induced proctitis.
Am J Gastroenterol 1998, 83:1140–1144.
19. Lim JF, Tjandra JJ, Hiscock R, Chao MW, Gibbs P: Preoperative
chemoradiation for rectal cancer causes prolonged pudendal nerve
terminal motor latency. Dis Colon Rectum 2006, 49:12–19.
20. Lee TG, Kang SB, Heo SC, Jeong SY, Park KJ: Risk factors for persistent anal
incontinence after restorative proctectomy in rectal cancer patients with anal
incontinence: prospective cohort study.World J Surg 2011, 35:1918–1924.
doi:10.1186/1748-717X-8-203
Cite this article as: Kye et al.: Short–term effects of neoadjuvant
chemoradiation therapy on anorectal function in rectal cancer patients:
a pilot study. Radiation Oncology 2013 8:203.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
